Skip to content

Trunerox 10% CBD Formula

Avicanna’s first pharmaceutical preparation (Trunerox) is in the drug registration stage in South America.

Trunerox™ – 10% CBD (100 mg/ml Cannabidiol)

Leveraging Avicanna’s scientific platform, vertical integration, and real-world evidence

Pharmaceutical preparation under GMP standards with completed technical dossier

Expected marketing authorization durign 2022 in Colombia, Ecuador, Argentina, Mexico and Brazil

Utilizing Avicanna’s proprietary formulations and vertical integration to deliver a pharmaceutical CBD preparation with affordable pricing into the Latin American Markets.

Contact Us